Latest Knoll Capital Management, LP Stock Portfolio

$180Million– No. of Holdings #37

Knoll Capital Management, LP Performance:
2026 Q1: -12.94%YTD: -12.94%2025: 28.31%

Performance for 2026 Q1 is -12.94%, and YTD is -12.94%, and 2025 is 28.31%.

About Knoll Capital Management, LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Knoll Capital Management, LLC reported an equity portfolio of $180.2 Millions as of 31 Mar, 2026.

The top stock holdings of Knoll Capital Management, LLC are , PHYS, RGLD. The fund has invested 10.9% of it's portfolio in BIOHAVEN PHARMACTL HLDG CO and 7.6% of portfolio in SPROTT PHYSICAL GOLD TRUST.

The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), SPDR GOLD TRUST (GLD) and ISHARES SILVER TRUST (SLV) stocks. They significantly reduced their stock positions in ALTIMMUNE INC (ALT), CENTERRA GOLD INC (CGAU) and KINROSS GOLD CORP (KGC). Knoll Capital Management, LLC opened new stock positions in SPROTT PHYSICAL GOLD TRUST (PHYS), SPROTT PHYSICAL SILVER TRUST (PSLV) and GOLD RTY CORP (GROY). The fund showed a lot of confidence in some stocks as they added substantially to ABEONA THERAPEUTICS (ABEO), TRIPLE FLAG PRECIOUS METALS (TFPM) and FRANCO NEV CORP (FNV).
Knoll Capital Management, LP Equity Portfolio Value
Last Reported on: 15 May, 2026

Knoll Capital Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Knoll Capital Management, LLC made a return of -12.94% in the last quarter. In trailing 12 months, it's portfolio return was 15.46%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
sprott physical gold trust13,717,200
sprott physical silver trust5,418,480
gold rty corp3,580,000
elemental rty corp943,000
versamet royalties corp633,565
amrize ltd513,983
pharming group nv67,508
or royalties8,555

New stocks bought by Knoll Capital Management, LP

Additions

Ticker% Inc.
abeona therapeutics105
triple flag precious metals95.58
franco nev corp28.00

Additions to existing portfolio by Knoll Capital Management, LP

Reductions

Ticker% Reduced
altimmune inc-85.73
centerra gold inc-27.82
kinross gold corp-21.95

Knoll Capital Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
applied therapeutics inc-605,000
avadel pharmaceuticals plc-12,930,000
ishares silver trust-5,153,600
spdr gold trust-12,681,900

Knoll Capital Management, LP got rid off the above stocks

Sector Distribution

Knoll Capital Management, LLC has about 62.3% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Basic Materials
  • Industrials
Sector%
Others62.3
Healthcare22.6
Basic Materials12.8
Industrials1.4

Market Cap. Distribution

Knoll Capital Management, LLC has about 9.3% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • MID-CAP
Category%
UNALLOCATED62.3
SMALL-CAP18.2
LARGE-CAP9.3
MICRO-CAP4.8
MID-CAP4.6

Stocks belong to which Index?

About 20.9% of the stocks held by Knoll Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others79.1
RUSSELL 200019.2
S&P 5001.7
Top 5 Winners (%)%
ORGS
orgenesis, inc.
300.0 %
CRDL
cardiol therapeutics inc
41.7 %
elicio therapeutics inc
34.3 %
SSRM
ssr mining in
34.1 %
CGAU
centerra gold inc
20.5 %
Top 5 Winners ($)$
SSRM
ssr mining in
1.8 M
AEM
agnico eagle mines ltd
1.8 M
elicio therapeutics inc
1.7 M
RGLD
royal gold inc.
1.7 M
CGAU
centerra gold inc
1.5 M
Top 5 Losers (%)%
ALDX
aldeyra therapeutics inc
-67.4 %
NUVB
nuvation bio inc
-52.1 %
ENTX
entera bio ltd
-43.3 %
OCUL
ocular therapeutix inc.
-30.1 %
biohaven pharmactl hldg co
-25.1 %
Top 5 Losers ($)$
ALDX
aldeyra therapeutics inc
-19.1 M
NUVB
nuvation bio inc
-7.0 M
biohaven pharmactl hldg co
-6.6 M
ENTX
entera bio ltd
-4.9 M
OCUL
ocular therapeutix inc.
-2.2 M

Knoll Capital Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Knoll Capital Management, LP

Knoll Capital Management, LLC has 37 stocks in it's portfolio. About 61.9% of the portfolio is in top 10 stocks. ALDX proved to be the most loss making stock for the portfolio. SSRM was the most profitable stock for Knoll Capital Management, LLC last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions